ISSAR Pharma Announces Out-Licensing of Its Peptide-Based NCEs
ISSAR Pharma, the only company in India which focuses on the research and development of New Chemical Entities (NCE), is licensing out its NCEs based on peptide technology, opening opportunities for fruitful partnerships. Hyderabad (Telangana) [India], April 29: ISSAR Pharmaceuticals, the Pioneer in Peptide Technology and peptide drug innovation, has decided to license out their…
Read More “ISSAR Pharma Announces Out-Licensing of Its Peptide-Based NCEs” »